REZMYG 5 MG ORODISPERSIBLE TABLET 18 PCS
For more detailed product information, please refer to official sources such as Nahdi Online , , or , and consult with a healthcare professional.
Product Overview
REZMYG 5 MG Orodispersible Tablets, manufactured by Teva, are specifically designed for the rapid and effective treatment of acute migraine attacks.
These fast-dissolving oral tablets provide convenient relief for individuals experiencing the debilitating symptoms of migraine, offering a non-narcotic solution.
REZMYG helps to alleviate migraine pain, nausea, and sensitivity to light and sound, allowing for quicker recovery from an attack.
Benefits of Use
- Rapid onset of action for quick relief from acute migraine symptoms.
- Effectively targets migraine-associated symptoms including headache pain, nausea, and sensitivity to light (photophobia) and sound (phonophobia).
- Convenient orodispersible form that dissolves quickly on the tongue without the need for water, making it ideal for use on the go.
- Provides non-narcotic relief from debilitating migraine attacks.
How to Use
- Take one REZMYG 5 MG Orodispersible Tablet as soon as migraine symptoms begin.
- Place the tablet on your tongue and allow it to dissolve completely. It will dissolve quickly and can be swallowed with saliva.
- Do not chew or crush the tablet, as this may affect its efficacy.
- If the migraine returns after initial relief, a second tablet may be taken after at least 2 hours.
- Do not exceed a total dose of 20 MG (four 5 MG tablets) within a 24-hour period.
- Always consult your healthcare professional for personalized dosage and instructions regarding REZMYG.
Caution & Warnings
- REZMYG is intended for the acute treatment of migraine attacks and should not be used for migraine prevention.
- Consult your doctor before use if you have a history of heart disease, stroke, uncontrolled high blood pressure, or other cardiovascular conditions.
- Avoid concomitant use with other triptans, ergot-type medications, or monoamine oxidase (MAO) inhibitors, as this may lead to serious side effects.
- REZMYG may cause dizziness or drowsiness; exercise caution when driving or operating machinery.
- If you experience chest pain, shortness of breath, or any unusual symptoms after taking REZMYG, seek immediate medical attention.
- Keep REZMYG out of the reach of children and pets.
Ingredients
Active Ingredient: Rizatriptan (as benzoate) 5 MG.
Inactive Ingredients: Typically include mannitol, crospovidone, aspartame, peppermint flavour, magnesium stearate, and red iron oxide. Please refer to the product packaging insert for a complete and precise list of ingredients.
Product Details
- Form: Orodispersible Tablet
- Strength: 5 MG
- Package Size: 18 Tablets
- Manufacturer: Teva
- Drug Type: Prescription Only Medicine (POM)
- Administration Route: Oral
| Gtin | 18905091114515 |
|---|---|
| Recommended Sale Price | 78.25 |
| Is Wasfaty Product | No |
| Brand | REZMYG |
| Principle | Rizatriptan |
| Ingredient Name | CALCIUM CARBONATE |
| IBC | 18905091114515 |
| Drug Type | Prescription |
| Scientific Name | Rimegepant |
| Strength | 500 |
| Strength Unit | mg |
| Form | Orodispersible Tablets |
| Admin Route | Oral |
| Size | 5 |
| Size Unit | mg |
| Package Types | Blister pack, Tablets |
| Package Size | 18 Tablets |
| Storage conditions | Store at room temperature, away from moisture and direct heat, in original blister packaging. |
| Refrigerator Storage | false |
| Distribute area | Saudi Arabia |
